TY - JOUR
T1 - Predictive factors of lead failure in patients implanted with cardiac devices
AU - Aizawa, Yoshiyasu
AU - Negishi, Masachika
AU - Kashimura, Shin
AU - Nakajima, Kazuaki
AU - Kunitomi, Akira
AU - Katsumata, Yoshinori
AU - Nishiyama, Takahiko
AU - Kimura, Takehiro
AU - Nishiyama, Nobuhiro
AU - Fukumoto, Kotaro
AU - Tanimoto, Yoko
AU - Kohsaka, Shun
AU - Takatsuki, Seiji
AU - Fukuda, Keiichi
N1 - Funding Information:
We are grateful to Mr. John Martin for reading this manuscript. This work was supported by MEXT KAKENHI (grant no. 26461087 to Y. Aizawa), and by grants from the Ministry of Health, Labor and Welfare of Japan for Clinical Research on Intractable Diseases (grant no. H26-040 to K. Fukuda).
Publisher Copyright:
© 2015 Elsevier Ireland Ltd.All rights reserved.
PY - 2015/9/15
Y1 - 2015/9/15
N2 - Introduction Lead failures (LFs) are one of the most common complications in patients implanted with cardiovascular implantable electronic devices. LFs often cause serious secondary complications such as inappropriate ICD shocks or asystole. This study aimed to identify the clinical factors associated with the occurrence of LFs. Methods A total of 735 consecutive device implantations (mean age 67 ± 15 years, males 64%) performed at a single university hospital setting from 1997 to 2014 were included. The implanted devices consisted of 421 pacemakers, 250 implantable cardioverter defibrillators (ICD), 9 cardiac resynchronization therapy pacemakers (CRT-P), and 55 CRT defibrillators (CRT-D). The primary endpoint was the development of an LF. Results During a mean duration of 5.8 ± 4.3 years, 38 LFs developed in 31 patients (mean age 56 ± 14 years). LFs included 32 ICD (7 Sprint Fidelis, 2 Riata), and 6 pacing leads. Nine patients received inappropriate ICD shocks and 1 had syncope due to an LF. All patients underwent lead reinsertions with device replacements. Eight patients required opposite site implantations due to venous occlusions. The predictive factors of LFs were the age, male sex, taller body length, ICD vs. pacemaker, lesser lead number, extra-thoracic puncture of the axillary vein vs. a cut-down of the cephalic vein, use of recalled leads and patients with idiopathic ventricular fibrillation (IVF) and Brugada syndrome (BrS). Conclusion LFs occurred mainly with ICD leads. A lesser age, the puncture method, lead model, and diagnosis of IVF/BrS were associated with the development of LFs.
AB - Introduction Lead failures (LFs) are one of the most common complications in patients implanted with cardiovascular implantable electronic devices. LFs often cause serious secondary complications such as inappropriate ICD shocks or asystole. This study aimed to identify the clinical factors associated with the occurrence of LFs. Methods A total of 735 consecutive device implantations (mean age 67 ± 15 years, males 64%) performed at a single university hospital setting from 1997 to 2014 were included. The implanted devices consisted of 421 pacemakers, 250 implantable cardioverter defibrillators (ICD), 9 cardiac resynchronization therapy pacemakers (CRT-P), and 55 CRT defibrillators (CRT-D). The primary endpoint was the development of an LF. Results During a mean duration of 5.8 ± 4.3 years, 38 LFs developed in 31 patients (mean age 56 ± 14 years). LFs included 32 ICD (7 Sprint Fidelis, 2 Riata), and 6 pacing leads. Nine patients received inappropriate ICD shocks and 1 had syncope due to an LF. All patients underwent lead reinsertions with device replacements. Eight patients required opposite site implantations due to venous occlusions. The predictive factors of LFs were the age, male sex, taller body length, ICD vs. pacemaker, lesser lead number, extra-thoracic puncture of the axillary vein vs. a cut-down of the cephalic vein, use of recalled leads and patients with idiopathic ventricular fibrillation (IVF) and Brugada syndrome (BrS). Conclusion LFs occurred mainly with ICD leads. A lesser age, the puncture method, lead model, and diagnosis of IVF/BrS were associated with the development of LFs.
KW - Brugada syndrome
KW - Fidelis
KW - Idiopathic ventricular fibrillation
KW - Implantable cardioverter defibrillator
KW - Lead failure
KW - Pacemaker
KW - Riata
UR - http://www.scopus.com/inward/record.url?scp=84941558523&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941558523&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2015.07.055
DO - 10.1016/j.ijcard.2015.07.055
M3 - Article
C2 - 26218183
AN - SCOPUS:84941558523
SN - 0167-5273
VL - 199
SP - 277
EP - 281
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -